Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2003
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073703 Autoimmune disease; antiinflammatory agents
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073676 Dissolving in aqueous carrier; antiallergens
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator
04/17/2003US20030072824 Having anti-oxidant, gastric mucosa injury inhibiting, aldose reductase inhibiting, blood glucose level elevation inhibiting action, platelet agglutination accelerating action, alcohol absorption inhibition, anti-inflammation properties
04/17/2003US20030072756 Combination therapy using an IL-1 inhibitor and methotrexate
04/17/2003US20030072753 Virus-like particles for the induction of autoantibodies
04/17/2003US20030072747 Platelet-activating factor acetylhydrolase
04/17/2003US20030072737 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
04/17/2003US20030072736 Human tumor necrosis factor receptor TR16
04/17/2003US20030070903 Systems, methods and apparatuses for manufacturing dosage forms
04/17/2003CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003CA2464662A1 Modulation of the expression of genes dependent on stat-1
04/17/2003CA2463507A1 Methods for the synthesis of substituted purines
04/17/2003CA2463496A1 Method of obtaining an extract of ginger
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003CA2462892A1 Human 3 relaxin
04/17/2003CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2461435A1 Angiopoietin-2 specific binding agents
04/17/2003CA2461343A1 Mammalian c-type lectins
04/17/2003CA2461064A1 Inhibition of stat-1
04/17/2003CA2460480A1 Molecules for disease detection and treatment
04/17/2003CA2460476A1 Protein modification and maintenance molecules
04/17/2003CA2458645A1 Intracellular signaling molecules
04/17/2003CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr
04/16/2003WO2003032915A2 Viral inhibition by n-docosanol
04/16/2003EP1302542A1 Novel physiologically active peptide and use thereof
04/16/2003EP1302476A1 Reduced fk228 and use thereof
04/16/2003EP1302461A1 Tnf-alpha production inhibitors
04/16/2003EP1302201A1 Pharmaceutical composition improved in peroral absorbability
04/16/2003EP1302115A1 Use of cystathionine
04/16/2003EP1301598A2 Cell cycle proteins and mitosis-associated molecules
04/16/2003EP1301595A2 G-protein coupled receptors
04/16/2003EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
04/16/2003EP1301535A2 G-protein coupled receptors
04/16/2003EP1301534A2 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis
04/16/2003EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies
04/16/2003EP1301522A1 Novel compounds and methods
04/16/2003EP1301517A1 Thienopyrrolidinones
04/16/2003EP1301516A1 Modulators of protein tyrosine phosphatases (ptpases)
04/16/2003EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
04/16/2003EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
04/16/2003EP1301506A1 Cyclic amino acid derivatives
04/16/2003EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
04/16/2003EP1301497A1 Colchinol derivatives as vascular damaging agents
04/16/2003EP1301495A2 Inhibitors of copper-containing amine oxidases
04/16/2003EP1301490A2 5-substituted 2-aryl-4-pyrimidinones
04/16/2003EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
04/16/2003EP1301211A2 Multifunctional nanodevice platform
04/16/2003EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
04/16/2003EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide
04/16/2003EP1301193A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
04/16/2003EP1301176A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles
04/16/2003EP1301173A1 A medicinal aerosol formulation
04/16/2003EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/16/2003EP1181017B1 Metalloprotease inhibitors
04/16/2003EP1158967B1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
04/16/2003EP1086682B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
04/16/2003EP1054667B1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
04/16/2003EP1053240B1 Glucocorticoid-selective antiinflammatory agents
04/16/2003EP1024807B1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
04/16/2003EP1007505B1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
04/16/2003EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential
04/16/2003EP0942896B1 Substituted phenols and thiophenols useful as antioxidant agents
04/16/2003EP0920322B1 Use of modified autologous blood for the treatment of autoimmune diseases
04/16/2003EP0912185B1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
04/16/2003EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
04/16/2003EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
04/16/2003EP0769958B1 Inhibitors of leukocyte adhesion
04/16/2003EP0642356B1 Antibodies to p-selectin and their uses
04/16/2003CN1411461A Thienopyridine derivatives and their preparing process and use
04/16/2003CN1411458A Saccharin derivatives as orally active elastase inhibitors
04/16/2003CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
04/16/2003CN1411447A Polymorphic crystalline forms of celecoxib
04/16/2003CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
04/16/2003CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
04/16/2003CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
04/16/2003CN1411436A Hydroxamic acid derivative as inhibitor of formation of soluble human CD23
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/16/2003CN1411373A Novel processes for making-and new crystalline form of-leflunomide
04/16/2003CN1410536A Human source aprotinin gene, protein of said gene code and its application
04/16/2003CN1410123A Chiese medicine preparation for treating parenchyma pain
04/16/2003CN1410118A Chinese patent medicine for suppressing pain without habituation and its preparation method
04/16/2003CN1410112A Fuyuan plaster for promoting blood circulation